학술논문
Safety, tolerability, and immunogenicity of a SARS-CoV-2 recombinant spike RBD protein vaccine: A randomised, double-blind, placebo-controlled, phase 1-2 clinical trial (ABDALA Study)
Document Type
Article
Author
Hernández-Bernal, Francisco; Ricardo-Cobas, Maria C.; Martín-Bauta, Yenima; Navarro-Rodríguez, Zadis; Piñera-Martínez, Marjoris; Quintana-Guerra, Joel; Urrutia-Pérez, Karen; Urrutia-Pérez, Klaudia; Chávez-Chong, Cristina O.; Azor-Hernández, Jorge L.; Rodríguez-Reinoso, José L.; Lobaina-Lambert, Leonardo; Colina-Ávila, Elizabeth; Bizet-Almeida, Jacqueline; Rodríguez-Nuviola, Jeniffer; del Valle-Piñera, Sergio; Ramírez-Domínguez, Mayara; Tablada-Ferreiro, Elisangela; Alonso-Valdés, Marel; Lemos-Pérez, Gilda; Guillén-Nieto, Gerardo E.; Palenzuela-Díaz, Ariel; Noa-Romero, Enrique; Limonta-Fernández, Miladys; Fernández-Ávila, Juan M.; Ali-Mros, Nabil A.; del Toro-Lahera, Lianne; Remedios-Reyes, Rossana; Ayala-Ávila, Marta; Muzio-González, Verena L.
Source
In eClinicalMedicine April 2022 46
Subject
Language
ISSN
2589-5370